Linping Cao

Dr. Linping Cao


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2024 in Environment International
Verified
Journal Article
Open access
JHJiawei Hong
Jiawei Hong
KDKeyi Du
Keyi Du
HJHangbiao Jin
Hangbiao Jin
YCYuanchen Chen
Yuanchen Chen
YJYifan Jiang
Yifan Jiang
LCLinping Cao
Linping Cao
Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are synthetic chemicals, encompassing compounds like perfluorooctane sulfonate (PFOS), which have widespread applications across various industries, including food packaging and firefighting. In recent years, China has increasingly employed 6:2 Cl-PFESA as an alternative to PFOS. Although the association between PFAS exposure and hepatocellular carcinoma (HCC) has been demonstrated, the underlying mechanisms that promote HCC proliferation are uncleared. Therefore, we aimed to investigate the effects and differences of PFOS and 6:2 Cl-PFESA on HCC proliferation through in vivo and in vitro tumor models. Our results reveal that both PFOS and 6:2 Cl-PFESA significantly contribute to HCC proliferation in vitro and in vivo. Exposure led to reduced population doubling times, enlarged cell colony sizes, enhanced DNA synthesis efficiency, and a higher proportion of cells undergoing mitosis. Furthermore, both PFOS and 6:2 Cl-PFES) have been shown to activate the PI3K/AKT/mTOR signaling pathway and inhibit necroptosis. This action consequently enhances the proliferation of HCC cells. Our phenotypic assay findings suggest that the tumorigenic potential of 6:2 Cl-PFESA surpasses that of PFOS; in a subcutaneous tumor model using nude mice, the mean tumor weight for the 6:2 Cl-PFESA-treated cohort was 2.33 times that observed in the PFOS cohort (p < 0.01). Despite 6:2 Cl-PFESA being considered a safer substitute for PFOS, the pronounced effects of this chemical on HCC cell growth warrant a thorough assessment of hepatotoxicity risks linked to its usage.

28 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
LCLinping Cao
Linping Cao
WQWang Qing
Wang Qing
JHJiawei Hong
Jiawei Hong
HYHan Yuzhe
Han Yuzhe
WZWeichen Zhang
Weichen Zhang
KLKewei Liang
Kewei Liang
In this study, we considered preoperative prediction of microvascular invasion (MVI) status with deep learning (DL) models for patients with early-stage hepatocellular carcinoma (HCC) (tumor size ≤ 5 cm). Two types of DL models based only on venous phase (VP) of contrast-enhanced computed tomography (CECT) were constructed and validated. From our hospital (First Affiliated Hospital of Zhejiang University, Zhejiang, P.R. China), 559 patients, who had histopathological confirmed MVI status, participated in this study. All preoperative CECT were collected, and the patients were randomly divided into training and validation cohorts at a ratio of 4:1. We proposed a novel transformer-based end-to-end DL model, named MVI-TR, which is a supervised learning method. MVI-TR can capture features automatically from radiomics and perform MVI preoperative assessments. In addition, a popular self-supervised learning method, the contrastive learning model, and the widely used residual networks (ResNets family) were constructed for fair comparisons. With an accuracy of 99.1%, a precision of 99.3%, an area under the curve (AUC) of 0.98, a recalling rate of 98.8%, and an F1-score of 99.1% in the training cohort, MVI-TR achieved superior outcomes. Additionally, the validation cohort’s MVI status prediction had the best accuracy (97.2%), precision (97.3%), AUC (0.935), recalling rate (93.1%), and F1-score (95.2%). MVI-TR outperformed other models for predicting MVI status, and showed great preoperative predictive value for early-stage HCC patients.

13 November 2023 in Environmental Pollution
Verified
Journal Article
Closed access
JHJiawei Hong
Jiawei Hong
XWXiaoyan Wang
Xiaoyan Wang
HJHangbiao Jin
Hangbiao Jin
YCYuanchen Chen
Yuanchen Chen
YJYifan Jiang
Yifan Jiang
LCLinping Cao
Linping Cao

1 December 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
WZWeichen Zhang
Weichen Zhang
QWQing Wang
Qing Wang
KLKewei Liang
Kewei Liang
HLHaihao Lin
Haihao Lin
DWDongyan Wu
Dongyan Wu
LCLinping Cao
Linping Cao

5 June 2024 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
JHJiawei Hong
Jiawei Hong
KDKeyi Du
Keyi Du
WZWeichen Zhang
Weichen Zhang
JCJunran Chen
Junran Chen
HJHangbiao Jin
Hangbiao Jin
LCLinping Cao
Linping Cao

26 February 2020 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
WCWenjie Chin
Wenjie Chin
LCLinping Cao
Linping Cao
XLXi Liu
Xi Liu
YYYufu Ye
Yufu Ye
YLYuanxing Liu
Yuanxing Liu
SZShusen Zheng
Shusen Zheng
Background: Synchronous renal cell carcinoma metastasizing to the pancreas and subcutaneous tissue is very rare. Unusual metastatic sites require attention during follow-up of renal cell carcinoma. It is extremely rare for renal cell carcinoma to metastasize to the pancreas; it is also very rare for it to metastasize to the subcutaneous tissue and extremely rare for it to synchronously metastasize to the pancreas and subcutaneous tissue almost a decade after radical nephrectomy. It is well known that most pancreatic tumors are primary pancreatic adenocarcinoma. However, the pancreas can also be an uncommon site for metastasis. We present a rare case of synchronous metastasis of renal cell carcinoma to the pancreas and subcutaneous tissue; we believe it to be only the second such case reported to date. Case presentation: We describe a case of a 74-year-old Chinese man who was diagnosed with metastatic renal cell carcinoma to the pancreas and subcutaneous tissue at the same time, 10 years after left radical nephrectomy. He received distal pancreatectomy with spleen preservation plus resection of the subcutaneous tissue lesions on the left side of the anterior abdominal wall and right waist. Pathology showed that all resected metastatic tumors were of the clear cell type. The patient was seen in regular follow-up afterward. Conclusion: Synchronous metastatic renal cell carcinoma to the pancreas and subcutaneous tissue is very rare, and it might occur after primary tumor resection. Patients must undergo lifelong monitoring and follow-up with regular examination so that any possible metastasis can be detected early. The optimal resection strategy should involve adequate resection margins and maximal tissue preservation of the pancreas, because renal cell carcinoma metastasizing to the pancreas and subcutaneous tissue has a good prognosis with long-term survival.